Cargando…
Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program
Background In the Dutch colorectal (CRC) screening program, fecal immunochemical test (FIT)-positive individuals are referred for colonoscopy. If no relevant findings are detected at colonoscopy, individuals are reinvited for FIT screening after 10 years. We aimed to assess CRC risk after a negativ...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684335/ https://www.ncbi.nlm.nih.gov/pubmed/37793423 http://dx.doi.org/10.1055/a-2136-6564 |
_version_ | 1785151380417150976 |
---|---|
author | van de Schootbrugge-Vandermeer, Hilliene J. Kooyker, Arthur I. Wisse, Pieter H. A. Nagtegaal, Iris D. Geuzinge, Hiltje A. Toes-Zoutendijk, Esther de Jonge, Lucie Breekveldt, Emilie C. H. van Vuuren, Anneke J. van Kemenade, Folkert J. Ramakers, Christian R. B. Dekker, Evelien Lansdorp-Vogelaar, Iris Spaander, Manon C. W. van Leerdam, Monique E. |
author_facet | van de Schootbrugge-Vandermeer, Hilliene J. Kooyker, Arthur I. Wisse, Pieter H. A. Nagtegaal, Iris D. Geuzinge, Hiltje A. Toes-Zoutendijk, Esther de Jonge, Lucie Breekveldt, Emilie C. H. van Vuuren, Anneke J. van Kemenade, Folkert J. Ramakers, Christian R. B. Dekker, Evelien Lansdorp-Vogelaar, Iris Spaander, Manon C. W. van Leerdam, Monique E. |
author_sort | van de Schootbrugge-Vandermeer, Hilliene J. |
collection | PubMed |
description | Background In the Dutch colorectal (CRC) screening program, fecal immunochemical test (FIT)-positive individuals are referred for colonoscopy. If no relevant findings are detected at colonoscopy, individuals are reinvited for FIT screening after 10 years. We aimed to assess CRC risk after a negative colonoscopy in FIT-positive individuals. Methods In this cross-sectional cohort study, data were extracted from the Dutch national screening information system. Participants with a positive FIT followed by a negative colonoscopy between 2014 and 2018 were included. A negative colonoscopy was defined as a colonoscopy during which no more than one nonvillous, nonproximal adenoma < 10 mm or serrated polyp < 10 mm was found. The main outcome was interval post-colonoscopy CRC (iPCCRC) risk. iPCCRC risk was reviewed against the risk of interval CRC after a negative FIT (FIT IC) with a 2-year screening interval. Results 35 052 FIT-positive participants had a negative colonoscopy and 24 iPCCRCs were diagnosed, resulting in an iPCCRC risk of 6.85 (95 %CI 4.60–10.19) per 10 000 individuals after a median follow-up of 1.4 years. After 2.5 years of follow-up, age-adjusted iPCCRC risk was approximately equal to FIT IC risk at 2 years. Conclusion Risk of iPCCRC within a FIT-based CRC screening program was low during the first years after colonos-copy but, after 2.5 years, was the same as the risk in FIT-negative individuals at 2 years, when they are reinvited for screening. Colonoscopy quality may therefore require further improvement and FIT screening interval may need to be reduced after negative colonoscopy. |
format | Online Article Text |
id | pubmed-10684335 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-106843352023-11-30 Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program van de Schootbrugge-Vandermeer, Hilliene J. Kooyker, Arthur I. Wisse, Pieter H. A. Nagtegaal, Iris D. Geuzinge, Hiltje A. Toes-Zoutendijk, Esther de Jonge, Lucie Breekveldt, Emilie C. H. van Vuuren, Anneke J. van Kemenade, Folkert J. Ramakers, Christian R. B. Dekker, Evelien Lansdorp-Vogelaar, Iris Spaander, Manon C. W. van Leerdam, Monique E. Endoscopy Background In the Dutch colorectal (CRC) screening program, fecal immunochemical test (FIT)-positive individuals are referred for colonoscopy. If no relevant findings are detected at colonoscopy, individuals are reinvited for FIT screening after 10 years. We aimed to assess CRC risk after a negative colonoscopy in FIT-positive individuals. Methods In this cross-sectional cohort study, data were extracted from the Dutch national screening information system. Participants with a positive FIT followed by a negative colonoscopy between 2014 and 2018 were included. A negative colonoscopy was defined as a colonoscopy during which no more than one nonvillous, nonproximal adenoma < 10 mm or serrated polyp < 10 mm was found. The main outcome was interval post-colonoscopy CRC (iPCCRC) risk. iPCCRC risk was reviewed against the risk of interval CRC after a negative FIT (FIT IC) with a 2-year screening interval. Results 35 052 FIT-positive participants had a negative colonoscopy and 24 iPCCRCs were diagnosed, resulting in an iPCCRC risk of 6.85 (95 %CI 4.60–10.19) per 10 000 individuals after a median follow-up of 1.4 years. After 2.5 years of follow-up, age-adjusted iPCCRC risk was approximately equal to FIT IC risk at 2 years. Conclusion Risk of iPCCRC within a FIT-based CRC screening program was low during the first years after colonos-copy but, after 2.5 years, was the same as the risk in FIT-negative individuals at 2 years, when they are reinvited for screening. Colonoscopy quality may therefore require further improvement and FIT screening interval may need to be reduced after negative colonoscopy. Georg Thieme Verlag KG 2023-10-04 /pmc/articles/PMC10684335/ /pubmed/37793423 http://dx.doi.org/10.1055/a-2136-6564 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | van de Schootbrugge-Vandermeer, Hilliene J. Kooyker, Arthur I. Wisse, Pieter H. A. Nagtegaal, Iris D. Geuzinge, Hiltje A. Toes-Zoutendijk, Esther de Jonge, Lucie Breekveldt, Emilie C. H. van Vuuren, Anneke J. van Kemenade, Folkert J. Ramakers, Christian R. B. Dekker, Evelien Lansdorp-Vogelaar, Iris Spaander, Manon C. W. van Leerdam, Monique E. Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program |
title | Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program |
title_full | Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program |
title_fullStr | Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program |
title_full_unstemmed | Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program |
title_short | Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program |
title_sort | interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684335/ https://www.ncbi.nlm.nih.gov/pubmed/37793423 http://dx.doi.org/10.1055/a-2136-6564 |
work_keys_str_mv | AT vandeschootbruggevandermeerhillienej intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram AT kooykerarthuri intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram AT wissepieterha intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram AT nagtegaalirisd intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram AT geuzingehiltjea intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram AT toeszoutendijkesther intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram AT dejongelucie intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram AT breekveldtemiliech intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram AT vanvuurenannekej intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram AT vankemenadefolkertj intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram AT ramakerschristianrb intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram AT dekkerevelien intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram AT lansdorpvogelaariris intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram AT spaandermanoncw intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram AT vanleerdammoniquee intervalpostcolonoscopycolorectalcancerfollowinganegativecolonoscopyinafecalimmunochemicaltestbasedscreeningprogram |